2019, Number 2
Correlation between Intima-media Thickness with Pulse Wave Velocity, and Ankle-Brachial Index in Subjects with Metabolic Syndrome
Language: Spanish
References: 12
Page: 45-49
PDF size: 151.19 Kb.
ABSTRACT
Background: Arterial stiffness is an independent predictor of cardiovascular mortality, pulse wave velocity (PWV) is the standard for measuring arterial stiffness. Ankle-brachial index (ABI) ‹ 0.9 triples the risk of cardiovascular death. The measurement of the intima-media thickness (IMT) of the carotid arteries has a predictive value for the appearance of vascular disease. Objective: To establish if the IMT correlates with the PWV and the ABI in subjects with metabolic syndrome. Method: 35 subjects with metabolic syndrome were evaluated. In all of them, PWV was determined with a piece of Arteriograph equipment. The IMT was determined by B-mode ultrasonography of the carotid arteries, with high resolution equipment using a 7.5 MHz linear transducer. The ABI was quantified with a 5 MHz Doppler device, according to the usual technique. The statistical methods used were the Fisher Exact Test and the Pearson correlation coefficient. Results: A significant correlation between the IMT with the PWV (r = 0.57, r2 = 0.32, p = 0.0006) was found. We did not find a correlation between the ABI and the IMT (r = -0.31, p = 0.08). When evaluating the risk of presenting increased IMT in patients with increased PWV, we found statistical significance (p = 0.033). Only one patient with PWV› 9 m / S presented IMT ≤ 0.9 mm. Conclusion: We found that PWV was significantly correlated with IMT in subjects with metabolic syndrome. The measurement of pulse wave velocity is a tool that provides valuable information in the overall assessment of the cardiovascular risk of these patients.REFERENCES
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, y cols. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127-e248.
Rosas Guzmán J., González Chávez A., Aschner P., Bastarrachea R. y col. Epidemiología, Diagnóstico, Control, Prevención y Tratamiento del Síndrome Metabólico en Adultos. Consenso Latinoamericano de la Asociación Latinoamericana de Diabetes (ALAD) Epidemiología, Diagnóstico, Control, Prevención y Tratamiento del Síndrome Metabólico en Adultos. Revista ALAD 2010;18:25-44.
Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, y cols. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE. Endocr Pract. 2017 Apr;23(Suppl 2):1-87..